PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C0015695|fatty liver |
| Sentences | 3 |
| PubMedID- 25905490 | In brief, 1,069 subjects aged 18 to 72 years and randomly selected from the government census database agreed to participate in the screening project from may 2008 to september 2010. those with active malignancy, metallic implants or other contraindications to magnetic resonance imaging, positive hepatitis b surface antigen or antibody against hepatitis c virus, secondary causes of fatty liver (e.g. |
| PubMedID- 22087124 | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients. |
| PubMedID- 23630437 | Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease. |
Page: 1